SCHEMBL821552

SCHEMBL821552

CCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)C(C)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.71
KDM4E B2RXH2 1/20 0.71
DUSP3 P51452 1/20 0.71
MEN1 O00255 1/20 0.71
KMT2A Q03164 1/20 0.71
MAPT P10636 1/20 0.70
ENPP2 Q13822 6/20 0.66
LPAR1 Q92633 6/20 0.66
LPAR4 Q99677 3/20 0.66
LPAR5 Q9H1C0 3/20 0.66
LPAR2 Q9HBW0 3/20 0.66
LPAR3 Q9UBY5 3/20 0.66
LPAR6 P43657 2/20 0.66
DGKA P23743 2/20 0.60
ALDH1A1 P00352 1/20 0.58
TRPV1 Q8NER1 2/20 0.57
CES2 O00748 1/20 0.57
P2RY10 O00398 1/20 0.54
GPR174 Q9BXC1 1/20 0.54
GPR34 Q9UPC5 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19944297 0.91 LMNA (0.83) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL17129723 0.91 LMNA (0.83) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL9463709 0.91 LMNA (0.83) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL896977 0.91 LMNA (0.83) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL21660226 0.91 LMNA (0.83) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL2734722 0.91 LMNA (0.83) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL3941258 0.91 LMNA (0.83) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL3109961 0.91 LMNA (0.83) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL2183839 0.91 LMNA (0.83) LMNAKDM4EDUSP3MEN1KMT2A
SCHEMBL7576639 0.91 LMNA (0.83) LMNAKDM4EDUSP3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110287102-A1 CHAIN EXTENDERS POLYNOVO BIOMATERIALS PTY LIMITED (AU) 2011-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110287102-A1 CHAIN EXTENDERS UMPS, PUF60, SMCHD1 LMNA 570/4885KDM4E 1903/4885DUSP3 4733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.